James A. Bianco’s beneficial ownership in TuHURA Biosciences fell below 5% to approximately 4.6% after the issuance of 1,878,287 common shares to Parkview Holdings One LLC. For investors, the change ended Bianco’s Section 13(d) reporting obligations and constituted his final ownership-report amendment, while he remains president, CEO and a director.
Key Highlights
- Bianco’s position includes 2,173,307 common shares and Options for 912,212 shares exercisable within 60 days.
- The ownership calculation is based on 65,758,360 common shares outstanding as of August 18, 2026.
- Bianco remains TuHURA’s president, chief executive officer and a director after the reporting-status change.
TuHURA Biosciences, Inc. (NASDAQ: HURA) saw President and CEO James A. Bianco’s beneficial ownership fall below 5% to approximately 4.6% after the company issued additional common stock. The change took effect on August 18, 2026, when Bianco ceased to be a beneficial owner of more than 5%.
Bianco’s Stake Drops Below the Reporting Threshold
Bianco beneficially owns 3,085,519 shares, equal to approximately 4.6% of TuHURA Biosciences’ outstanding common stock. His position consists of 2,173,307 common shares and options for 912,212 additional common shares exercisable within 60 days. The ownership percentage is calculated using 65,758,360 shares outstanding as of August 18, 2026, with Bianco holding sole voting and dispositive power over the reported position. TuHURA issued 1,878,287 common shares to Parkview Holdings One LLC under a fee letter dated April 21, 2026.
Reporting Obligations End as Bianco Retains Executive Roles
The reduction came from dilution tied to the share issuance, not from an Acquisition or disposition of securities by Bianco. No funds were used or received by him in connection with the decrease. The amendment was signed August 28, 2026, and Bianco continues as TuHURA’s president, chief executive officer and director.
Peers Moving on This News
- Connect Biopharma Holdings Limited (NASDAQ: CNTB) up 3.9%
- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) up 1.2%
- Vaxart Inc (OTC: VXRT) down 3.9%




Please wait processing your request...